Clinical Trial 12083

San Antonio, TX 78229

Study Summary:

Tardive Dyskinesia is a neurological disorder which is typically characterized by involuntary movements of the lips, tongue, jaw and face, as well as limbs and trunk. Depending on symptom severity, these movements can potentially cause injuries and affect daily activities.

The purpose of this trial is to assess the safety and effectiveness of an investigational drug in involuntary movements associated with Tardive Dyskinesia in patients with Schizophrenia or Schizoaffective Disorder.

The study would require you to complete 32 visits over an 11 week period. Compensation for time and travel may be available.

Qualified Participants Must:

• Be 18 to 65 years of age
• Have a diagnosis of schizophrenia or schizoaffective disorder
• Have a diagnosis of Tardive Dyskinesia (for at least 3 months)
• Additional criteria may apply

Qualified Participants May Receive:

Compensation for time and travel may be available.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.